We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First US Trial Participant Receives Gimsilumab for COVID-19 and Acute Respiratory Distress Syndrome

News   Apr 16, 2020 | Original story from Temple Health

 
First US Trial Participant Receives Gimsilumab for COVID-19 and Acute Respiratory Distress Syndrome
 
 
Advertisement
 

RELATED ARTICLES

Making Plant Hormones in the Lab

News

Researchers have developed a method that might make the production of a biologically significant precursor of the plant hormone jasmonic acid more efficient and cheaper.

READ MORE

Study Explores How Ketamine Works Against Depression

News

The anesthetic drug ketamine administered in low doses, has been shown to help treat difficult-to-treat depression. A research team has now identified a key target for the drug – specific serotonin receptors in the brain.

READ MORE

Novel Radiotherapy Reduces Swallowing Difficulties in Head and Neck Cancer

News

A randomized study has found patients with head and neck cancer experienced less adverse side effects when treated with a new optimized intensity-modulated radiation therapy (IMRT) technique designed to reduce the risk of swallowing difficulties, known as dysphagia.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE